USPTO serial 79299712
ZTX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 13, 2022
- Examiner
- ALESKOW, DAVID HOWARD
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ZTX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Diagnostic, examination, and monitoring equipment, namely, medical diagnostic apparatus for testing cancer tissues incorporating recorded operating system software; medical imaging apparatus; image management systems for medical purposes, namely, medical imaging apparatus with embedded operating system and analytical software | ACTIVE | — |
| 035 | Database management for others, namely, input, processing, checking, storage and retrieval of computer data; data processing services in the nature of processing and control of computerized information; data, database, file and records management in relation to business management and administration; retail store services featuring image apparatus, computers, computer programs, pharmaceutical preparations, pharmaceutical goods and goods for medical diagnostics; compiling indexes of information for others relating to information, homepages and other resources available via global computer networks and other electronic communications networks; compilation of statistical data relating to medical research for business purposes | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and product design in the fields of medicine and pharmacology; industrial analysis services, namely, laboratory analysis services in the medical and pharmaceutical fields; industrial research in the field of medicine and pharmacology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; drug discovery services; providing information and data relating to pharmaceutical and medical research and development; software design and development; software as a service (SaaS) services featuring software for recording, transmission, reproduction, storage and processing of files, test results, documents, texts, videos and images in the pharmaceutical and medical fields; platform as a service (PaaS) featuring computer software platforms for processing of pharmaceutical and medical files, test results, documents, texts, sound and images; computer services, namely, cloud hosting provider services; programming of computer software for pharmaceutical and medical application for others; electronic data storage; electronic storage of electronic media, namely files, data, documents, text, videos and images; computer services, namely, electronic digitizing of photographic images for medical purposes | ACTIVE | — |
| 044 | Medical services; analysis and examination of medical images for purposes of medical diagnosis and providing medical advice relating to pharmacology; online analysis and examination of medical images for purposes of medical diagnosis and providing medical advice relating to pharmacology; medical laboratory analysis services relating to the medical treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; consultancy services relating to health care; conducting of medical studies for medical diagnostic or treatment purposes in the field of oncology; medical services provided by analysis and examination of medical files, data, documents, text, videos, sound and images; medical services provided online by analysis and examination of medical files, data, documents, text, videos, sound and images; providing medical information | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bioreperia AB
- Other trademarks owned by Bioreperia AB
- Other trademarks owned by Bioreperia AB
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ZTX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 14, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 13, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 13, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 13, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 13, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 5, 2022 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Aug 5, 2022 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Aug 5, 2022 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| May 30, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 11, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 11, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 28, 2022 | RFNP | REFUSAL PROCESSED BY IB | — |
| Feb 2, 2022 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Feb 1, 2022 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Feb 1, 2022 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Sep 2, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 3, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 3, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 28, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 28, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 14, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 24, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 24, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 24, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 24, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 16, 2021 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jun 12, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jan 24, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 30, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 29, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 18, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 15, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 14, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 10, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |